Get the Stockscreener App
0.69
1.40%
-0.0098
After Hours:
.69
Atara Biotherapeutics Inc Stock (ATRA) Forecast
The Atara Biotherapeutics Inc (ATRA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.7319, representing a +295.92% increase from the current price of $0.69. The highest analyst price target is $4.8199, and the lowest is $0.6438.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ATRA Price Target
Average 8.4466
(+1,124% Upside)
Is Atara Biotherapeutics Inc (ATRA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 46.98 | Neutral |
| STOCH(9,6) | 53.91 | Neutral |
| STOCHRSI(14) | 39.54 | Neutral |
| MACD(12,26) | -0.00499 | Sell |
| ADX(14) | 16.81 | Neutral |
| William %R | -61.67 | Neutral |
| CCI(14) | -43.59 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.6948
Sell
|
0.7011
Sell
|
| MA20 |
0.7156
Sell
|
0.705
Sell
|
| MA50 |
0.7172
Sell
|
0.7164
Sell
|
| MA100 |
0.6913
Sell
|
0.8004
Sell
|
| MA200 |
1.0776
Sell
|
1.2126
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ATRA could be considered a Strong Sell, with 17 technical analysis indicators signaling 0 Buy signals, 11 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on ATRA, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 46.98 indicates that ATRA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 53.91 indicates that ATRA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 39.54 indicates that ATRA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 16.81 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -43.59 indicates that ATRA is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term ATRA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Atara Biotherapeutics Inc financial reports and earnings history, Atara Biotherapeutics Inc (ATRA) stock could reach $29.25 by 2030, $13.78 by 2040 and $52.29 by 2050. See the projected annual prices until 2050 of the Atara Biotherapeutics Inc stock below:
- Atara Biotherapeutics Inc (ATRA) is expected to reach an average price of $2.1243 in 2035, with a high prediction of $2.5146 and a low estimate of $2.1343. This indicates an $207.88% rise from the last recorded price of $0.69.
- Atara Biotherapeutics Inc (ATRA) stock is projected to chart a bullish course in 2040, with an average price target of $13.76, representing an $1,894% surge from its current level. The forecast ranges from a conservative $13.87 to a sky-high $13.78.
- Our analysts predict Atara Biotherapeutics Inc (ATRA) to jump 4,766% by 2045, soaring from $33.72 to an average price of $33.58, potentially reaching $35.94. While $33.72 is the low estimate, the potential upside is significant.
- Atara Biotherapeutics Inc (ATRA) stock is expected to climb by 2050, reaching an average of $51.64, a $7,385% jump from its current level. However, a wide range of estimates exists, with high and low targets of $52.29 and $51.99, respectively, highlighting the market's uncertainty.
Atara Biotherapeutics Inc Stock (ATRA) Year by Year Forecast
Atara Biotherapeutics Inc Stock (ATRA) Price Forecast for 2024
Our forecast for ATRA stock price in 2024 now indicates an average price target of $8.1843 with a high forecast of $16.25 and a low forecast of $0.1193. The average prediction reflects an increase of +1,086% from the last recorded price of $0.69.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2024 | $3.01 | $0.6438 | $4.8199 | +336.24% |
| June, 2024 | $8.6065 | $5.4466 | $7.004 | +1,147% |
| July, 2024 | $10.61 | $9.1231 | $8.983 | +1,438% |
| August, 2024 | $15.65 | $12.57 | $15.00 | +2,168% |
| September, 2024 | $15.85 | $16.38 | $16.25 | +2,198% |
| October, 2024 | $15.57 | $14.89 | $14.90 | +2,156% |
| November, 2024 | $16.01 | $15.53 | $14.88 | +2,221% |
| December, 2024 | $14.68 | $15.15 | $15.92 | +2,027% |
Atara Biotherapeutics Inc Stock (ATRA) Price Forecast for 2025
Atara Biotherapeutics Inc Stock (ATRA) is expected to reach an average price of $12.58 in 2025, with a high prediction of $17.60 and a low estimate of $7.5604. This indicates an +1,723% rise from the last recorded price of $0.69.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $12.06 | $13.48 | $13.28 | +1,648% |
| February, 2025 | $10.94 | $11.11 | $11.16 | +1,486% |
| March, 2025 | $11.86 | $11.35 | $12.10 | +1,619% |
| April, 2025 | $13.54 | $13.02 | $13.39 | +1,862% |
| May, 2025 | $17.18 | $17.32 | $17.60 | +2,391% |
| June, 2025 | $16.64 | $16.75 | $16.91 | +2,311% |
| July, 2025 | $9.6444 | $13.59 | $16.78 | +1,298% |
| August, 2025 | $13.29 | $13.36 | $13.26 | +1,826% |
| September, 2025 | $9.7841 | $9.0975 | $9.8176 | +1,318% |
| October, 2025 | $10.83 | $9.9507 | $9.9106 | +1,470% |
| November, 2025 | $9.6372 | $9.1905 | $9.2273 | +1,297% |
| December, 2025 | $8.9103 | $7.5604 | $8.7137 | +1,191% |
Atara Biotherapeutics Inc Stock (ATRA) Price Forecast for 2026
The predicted value for Atara Biotherapeutics Inc (ATRA) in 2026 is set at an average of $4.0101. Estimates vary from a peak of $7.4668 to a trough of $0.5535, indicating an +481.18% surge from the present price of $0.69.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $8.6168 | $8.2102 | $7.0182 | +1,149% |
| February, 2026 | $2.1966 | $1.4766 | $6.9335 | +218.35% |
| March, 2026 | $1.6735 | $0.5535 | $7.4668 | +142.54% |
| April, 2026 | $1.613 | $1.0031 | $1.9069 | +133.77% |
| May, 2026 | $1.7195 | $1.3329 | $2.1371 | +149.21% |
| June, 2026 | $4.2327 | $3.2762 | $3.3227 | +513.43% |
| July, 2026 | $5.2992 | $4.486 | $4.2192 | +668.00% |
| August, 2026 | $4.2424 | $4.2624 | $3.8791 | +514.84% |
| September, 2026 | $2.5489 | $3.5689 | $3.779 | +269.41% |
| October, 2026 | $2.9554 | $1.7987 | $1.1554 | +328.32% |
| November, 2026 | $4.0886 | $3.7921 | $3.5319 | +492.55% |
| December, 2026 | $0.5251 | $1.3551 | $3.5152 | -23.90% |
Atara Biotherapeutics Inc Stock (ATRA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Atara Biotherapeutics Inc (ATRA) is $3.0238, with a high forecast of $5.8802 and a low forecast of $0.1674. This indicates an +338.23% increase from the last price of $0.69.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.2984 | $0.275 | $2.7184 | +233.10% |
| February, 2027 | $0.8519 | $0.2815 | $2.7185 | +23.46% |
| March, 2027 | $2.9587 | $0.1848 | $5.0886 | +328.80% |
| April, 2027 | $0.9922 | $0.6122 | $4.2254 | +43.80% |
| May, 2027 | $0.399 | $0.2257 | $3.8189 | -42.17% |
| June, 2027 | $1.4225 | $0.3776 | $2.9325 | +106.16% |
| July, 2027 | $3.834 | $0.1674 | $2.0649 | +455.65% |
| August, 2027 | $2.6172 | $2.9672 | $2.8806 | +279.30% |
| September, 2027 | $5.3037 | $3.2738 | $4.2937 | +668.65% |
| October, 2027 | $6.0002 | $5.1603 | $5.8802 | +769.60% |
| November, 2027 | $3.3334 | $4.7734 | $5.8568 | +383.10% |
| December, 2027 | $6.3399 | $2.2733 | $2.675 | +818.82% |
Atara Biotherapeutics Inc Stock (ATRA) Price Forecast for 2028
In 2028, Atara Biotherapeutics Inc (ATRA) is projected to reach an average price of $4.0759, with a high projection of $6.6131 and a low estimate of $1.5387. This indicates an +490.71% rise from the last price of $0.69.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $5.173 | $5.223 | $6.6131 | +649.72% |
| February, 2028 | $4.3496 | $5.0646 | $5.2363 | +530.37% |
| March, 2028 | $4.8961 | $5.0711 | $4.9478 | +609.58% |
| April, 2028 | $3.6026 | $3.7024 | $4.4227 | +422.12% |
| May, 2028 | $3.1658 | $3.6492 | $3.3391 | +358.80% |
| June, 2028 | $4.2523 | $3.114 | $3.4673 | +516.27% |
| July, 2028 | $1.4054 | $2.8754 | $3.8489 | +103.69% |
| August, 2028 | $1.702 | $1.5387 | $1.542 | +146.66% |
| September, 2028 | $2.9385 | $1.9952 | $2.1585 | +325.87% |
| October, 2028 | $2.5116 | $2.605 | $2.4241 | +264.00% |
| November, 2028 | $2.6081 | $2.4183 | $2.0083 | +277.99% |
| December, 2028 | $2.7547 | $2.6948 | $2.7297 | +299.23% |
Atara Biotherapeutics Inc Stock (ATRA) Price Forecast for 2029
The 2029 price forecast for Atara Biotherapeutics Inc Stock (ATRA) is $16.15 on average, with a high prediction of $32.23 and a low estimate of $0.0669. This represents an +2,240% increase from the previous price of $0.69.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.8778 | $2.1769 | $2.1313 | +172.15% |
| February, 2029 | $1.0643 | $1.1743 | $1.3245 | +54.25% |
| March, 2029 | $1.4009 | $1.161 | $1.2609 | +103.02% |
| April, 2029 | $0.464 | $0.784 | $1.1275 | -32.75% |
| May, 2029 | $0.4305 | $0.5205 | $0.4873 | -37.60% |
| June, 2029 | $1.1173 | $0.2904 | $0.2372 | +61.92% |
| July, 2029 | $0.1097 | $0.1602 | $0.6197 | -84.10% |
| August, 2029 | $32.80 | $0.0669 | $32.23 | +4,654% |
| September, 2029 | $30.70 | $32.49 | $32.04 | +4,350% |
| October, 2029 | $26.92 | $27.84 | $28.41 | +3,802% |
| November, 2029 | $26.37 | $28.78 | $26.85 | +3,722% |
| December, 2029 | $31.74 | $24.32 | $26.91 | +4,500% |
Atara Biotherapeutics Inc Stock (ATRA) Price Forecast for 2030
Atara Biotherapeutics Inc Stock (ATRA) is expected to reach an average price of $38.06 in 2030, with a high forecast of $45.94 and a low forecast of $30.19. This signifies an +5,416% surge from the last price of $0.69.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $36.55 | $30.19 | $29.25 | +5,198% |
| February, 2030 | $39.54 | $38.72 | $37.94 | +5,630% |
| March, 2030 | $40.98 | $39.97 | $39.47 | +5,839% |
| April, 2030 | $46.69 | $42.82 | $45.17 | +6,666% |
| May, 2030 | $45.20 | $45.84 | $45.94 | +6,451% |
| June, 2030 | $44.46 | $43.90 | $44.13 | +6,344% |
| July, 2030 | $44.35 | $44.08 | $43.46 | +6,327% |
| August, 2030 | $42.55 | $43.02 | $44.02 | +6,067% |
| September, 2030 | $39.33 | $40.19 | $41.04 | +5,600% |
| October, 2030 | $37.10 | $38.11 | $37.56 | +5,277% |
| November, 2030 | $38.26 | $38.46 | $38.61 | +5,445% |
| December, 2030 | $43.82 | $39.23 | $39.45 | +6,251% |
1.53%
3.38%
Cap:
|
Volume (24h):